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Abstract 
In today’s healthcare, intravenous (IV) therapy-related errors have become rampant and 
are responsible for a substantial portion of hospital injuries and deaths. In the last decade, 
however, since the development and implementation of “smart” IV pumps, a significant 
number of these IV medication errors have allegedly been reduced. The purpose of this 
paper is to discuss research surrounding an evaluation of the efficacy of smart IV pumps 
from a nursing perspective.   
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Efficacy of Smart Infusion Pumps from a Nursing Perspective 
Chapter 1: Introduction 
Introduction. 
 According to the U.S. Food & Drug Administration (2016), medication errors are 
responsible for at least one death every day and injure an astonishing 1.5 million people 
annually in the United States alone. Since IV medications, when compared with 
medications delivered via other routes, lead to higher systemic bodily concentrations and 
produce more rapid, potentially irreversible side effects, they are twice as likely to cause 
patient harm (Reston, 2013). Interestingly, Dulak (2005) estimates that, on average, 90% 
of hospitalized patients receive IV therapy in some capacity. Even though a medication 
mishap can occur anywhere in the prescribing, packaging, dispensing, administering, or 
monitoring processes, studies have indicated a larger than normal error rate (73%) in the 
actual administration process. The development of the smart IV pump, however, when 
used according to its design, has become a necessary component of a comprehensive and 
safe medication system, one that has successfully combatted error-related issues in this 
administration process. According to a recent survey, nearly 80% of hospitals in the 
United States currently utilize IV smart pump technology (Association for the 
Advancement of Medical Instrumentation [AAMI], 2016). 
Background of the Problem.  
The first programmable and very basic IV infusion pumps were developed more 
than 40 years ago (Proctor, 2014). Although these pumps were regarded as quite 
innovative at the time, they allowed the caregiver to input only limited information, such 
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as the medication’s volume-to-be-infused (VTBI) and the infusion rate. Lacking in 
technological sophistication, these pumps were risky in that they allowed for a wide 
range of medication programming with no alerts or alarms. For instance, all medications 
or blood products, even those considered high-alert or high-risk such as insulin, opiates, 
anti-coagulants, and sedatives could be infused at various rates starting as low as 0.1 
milliliters (mL) per hour to as high as 999 mL or more per hour. Over the years, these 
shortcomings have led to patients receiving lethal doses of medications. According to the 
U.S. Food & Drug Administration (2016), there were 56,000 reports of infusion-related 
incidents, including 710 deaths, resulting in the recall of 87 infusion pumps in the United 
States.  
It wasn’t until the late 1990s that smart IV pumps became the catalyst for change. 
A technological breakthrough, electronically erasable programmable read-only memory 
(EEPROM), made it possible for infusion pumps to contain safety software that could be 
customized to a hospital’s specific care area and tailored to meet individual patient needs 
(Proctor, 2014). Dose error-reduction systems (DERS) embedded within smart pumps 
have drastically improved the safety of IV infusion therapies. Unlike the former infusion 
pumps, predetermined drug libraries now produce an alert if pump programming exceeds 
hospital-established limits. Most smart pump software provides soft alerts, or soft stops, 
as well as hard alerts, or hard stops. Soft stops prompt users to reconsider a given drug 
dosage but have limitations in that they purely serve as a reminder and can be overridden; 
hard stops, however, abruptly prevent users from proceeding beyond the stated dose 
limits (Reston, 2013). Hard stops have proven to be more effective since they do not 
allow easy circumvention; smart pumps also log alerts including the time, date, drug, 
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concentration, programmed rate, and volume to be infused, allowing for valuable 
continuous quality improvement (CQI) data (Dulak, 2005). Most smart pump programs 
continuously display the name of the medication being infused, the dose, the rate, and the 
volume left to be infused, as well.  
It is evident that smart pumps now have the capability to prevent errors related to 
incorrect programming, but it is important to note that infusion-related errors can still 
occur if the wrong medication is given to the right patient, even if the pump is 
programmed correctly for the given medication. When a barcode medication 
administration system is integrated with a smart pump, however, the Five Rights of 
Medication Administration, which entails giving the right dose of the right medication to 
the right patient via the right route at the right time, becomes increasingly more accurate 
(Dulak, 2005). The numerous benefits of smart infusion technologies are clear, but it is 
important to understand that a smart pump’s efficacy is dependent on its user. Poor 
caregiver compliance with the drug library and dosage limits can drastically limit the 
advantages of smart pump decision support. Due to poor implementation and 
communication processes, one study conducted at an independent community hospital in 
Massachusetts found that the nursing staff utilized the smart pump library with only 37% 
of all infusions (Harding, n.d.). Some nurses felt that pump programming was frequently 
rushed or omitted altogether due to time constraints and competing work demands. In 
2005, another study that involved 735 cardiac surgery patients resulted in 14 adverse 
events. Perhaps these outcomes could have been prevented had the nursing staff not 
bypassed the drug library, an occurrence that happened 25% of the time (Reston, 2013). 
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Purpose of Study. 
 Thus, the purpose of this study is to gauge the extent of which obstetrical nurses 
at five East Tennessee hospitals perceive smart IV infusion pumps as helpful in 
improving patient safety by reducing harm. This research also aims to evaluate the 
prevalence of the proper use of smart IV pumps by the nursing staff. This study also 
gathers participant demographic information to assess for trends. 
Significance of Study. 
 Medication errors associated with IV pumps are historically proven to occur 
frequently, have the potential to cause harm, and are epidemiologically diverse (Husch, 
Sullivan, Rooney, Barnard, Fotis, Clarke, & Noskin, 2005). Proctor (2014), however, 
emphasizes the following benefits since the widespread implementation of smart IV 
pumps: fostered development of drug dose limits, standardization of concentration and 
dosing units, allowance of hospitals to configure pumps to match applications, provision 
of a plethora of infusion data, documentation of “good catches” from prevented 
programming errors, promotion of wireless connectivity/server applications, and 
identification of human factors and opportunities for manufacturer improvements. Since 
smart IV pumps demonstrate these numerous potential benefits to the already risky 
medication administration process, it is important to assess and encourage the proper use 
by the nurses who directly interact with them. Moreover, patients deserve the safest 
medical care and with the evolution of technological advancements, such as said smart IV 
pumps, desirable clinical outcomes have become even easier to attain.  
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Research Questions.  
 This anonymously-reported study contains three basic demographic questions 
followed by four smart IV pump-related statements in which the nurse is asked to rank 
his/her agreement, disagreement, or indifference accordingly. The last question provides 
an optional free-text comment box. The questions/statements and available responses are 
as follows:  
1. How long have you practiced BEDSIDE nursing?  
o <1 year  
o 1-3 years  
o 4-10 years  
o 11-20 years  
o >20 years 
2. What shift do you primarily work? 
o Dayshift  
o Nightshift 
o PRN 
o Varies/No Set Shift 
3. What is your age? 
o 22-30 Years Old  
o 31-40 Years Old 
o 41-50 Years Old 
o 51-60 Years Old 
o >60 Years Old 
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4. Smart IV pumps improve patient safety by reducing harm associated with 
medication errors. 
o Strongly Agree 
o Agree 
o Indifferent/Unsure 
o Disagree 
o Strongly Disagree 
5. The presence of embedded alerts, alarms, and/or functionalities that deny 
overriding have prevented the following IV-related error(s) in my clinical past 
(select all that apply): 
o Blood/Blood Product(s) 
o Medication(s) 
o IV Fluid(s) 
o None 
o Unsure 
6. Learning to operate smart IV pumps is easy and user-friendly. 
o Strongly Agree  
o Agree 
o Indifferent/Unsure 
o Disagree 
o Strongly Disagree 
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7. Smart IV pumps’ eventual integration with the eMAR, CPOE, and barcode 
scanning systems will further improve patient safety (i.e. scanning the patient’s 
armband + scanning the IV infusion(s) = automatic pump programming).  
o Strongly Agree 
o Agree 
o Indifferent/Unsure 
o Disagree 
o Strongly Disagree 
8. Comments? 
Definition of Terms.  
 For clarification purposes, the following is a list of terms used within this research 
project and their meanings: 
1. Anti-coagulants – a drug that acts to prevent blood clots by thinning the blood. 
2. Barcode medication administration system – the use of an electronic device, 
specifically a barcode scanner, that can read/scan the barcode on a patient’s 
hospital armband and on medication labels to aid in medication error 
prevention. 
3. Cardiac – of, or relating to, the human heart.  
4. Computerized provider order entry (CPOE) – an electronic means for a 
licensed healthcare provider to input patient care orders.  
5. Electronic medication administration record (eMAR) – an electronic report 
that serves as a legal record of drugs administered to a patient.   
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6. Infusion rate – the rate, usually measured as mL/minute or mL/hour, at which 
an IV-related therapy is administered to achieve therapeutic effectiveness. 
7. Insulin – a hormone that can be administrated via the IV or subcutaneous (SQ) 
route to decrease blood glucose levels.  
8. Intravenous – associated with, or administered into, a vein or veins.  
9. Opiates – a drug with Morphine-like effects, derived from opium. 
10. Sedatives – a drug that acts to induce sleep and/or promote calmness. 
11. Volume-to-be-infused (VTBI) – the total amount, usually measured in mL, 
that a patient is to receive of a provider-ordered IV therapy.  
Limitations.  
 This study is limited in that it will only be conducted and representative of one 
nursing specialty within five hospitals in the United States. Additionally, due to its 
localized distribution within East Tennessee facilities only, the survey is not 
geographically demonstrative of the entire nation. Additionally, Since the 
questionnaire/survey will be distributed via e-mail, it is highly unlikely that there will be 
a 100% response rate, especially with email recipients who don’t periodically check their 
email inbox or work often. This study is also limited in that it pertains to registered 
nurses practicing in an inpatient setting only, thus excluding ambulatory scenarios.  
Chapter 2: Review of Literature 
Method. 
 The purpose of this excerpt is to review the literature surrounding smart IV pumps 
to determine its efficacy, or lack thereof. Electronic articles for this literature review 
surrounding IV smart pumps were retrieved from the PubMed database. The search was 
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confined to the human species with publication dates between the years of 2005 to the 
present. Articles in the English language only were of interest. The search was further 
limited to the following free full-text articles: clinical trials, journal articles, meta-
analyses, reviews, and systematic reviews. The following search terms were employed: 
“IV smart pump” OR “IV smart pumps” OR “smart IV pump” OR “smart IV pumps” OR 
“smart pump” OR “smart pumps” OR “smart infusion technology” OR “smart infusion 
pump” OR “smart infusion pumps”. This very specific search yielded a total of 13 
articles. Of those, only 3 articles, which I will further discuss in this paper, contained data 
and pertinent information for the purposes of this research.   
Populations Studied. 
 The first study took place at Brigham and Women’s Hospital (BWH), a 793-bed 
tertiary care academic medical center in Boston, Massachusetts. Data was collected from 
55 inpatients from three different clinical areas: one medical intensive care unit (ICU), 
one surgical ICU, and one general surgical unit. The second study focused on a patient 
population from the ICU setting where 4,604 critically ill adults from one academic and 
one non-academic medical center were under scrutiny. This study examined 20,000 bed-
days of care in surgical, trauma/burn, and medical ICUs (Nuckols et al., 2008). The third 
case was conducted at a 500-bed women and pediatrics specialty hospital. 
Survey Method. 
 The literature revealed various methods for conducting research within each of 
the three studies. The first journal article used a prospective point prevalence approach. 
Designated observation nurses were responsible for comparing, at the bedside, the 
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medication, dose, and rate on the smart pump against the prescriber’s orders in the 
medical record. To confirm that an error was present, two observers had to be in 
agreement. An observational tool was developed to collect all IV medication error data. 
This particular tool was developed using the REDCap application, a Health Insurance 
Portability and Accountability Act (HIPAA)-compliant, web-based application that can 
be accessed via personal computers and/or cell phones (Nuckols et al., 2008). Figure 2 
below provides a screenshot of the REDCap tool:  
 
 
Figure 2. Screen shot of the data collection tool (REDCap). Copied from “Evaluation of 
Intravenous Medication Errors with Smart Infusion Pumps in an Academic Medical 
Center,” by Ohashi et al., 2013, AMIA Annual Symposium Proceedings, 2013, 1089–
1098. Copyright 2013 by AMIA. Copied with permission. 
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 By using a retrospective medical record review, the second study examined 
preventable IV-related adverse drug events (ADEs) in ICUs before and after both 
hospitals replaced conventional pumps with smart pumps (Nuckols, 2008). Both 
quantitative and qualitative methods were used. The third journal article conducted 
research as a retrospective pre-post study. 
Findings. 
 According to the first study conducted by Ohashi et al. (2013), 181 medications 
were observed during the data period. Of these observations, a whopping 171 (94.5%) 
had one or more errors associated with their administration, with the largest percentage 
representing a violation of hospital policy regarding labeling of medications and IV 
tubing. Regarding actual smart pump handling errors, however, observers found only four 
incidences. The first two cases involved two clamped medication IV bags, which were 
supposed to be unclamped/open; the latter two pump errors consisted of one with an 
incorrect rate and the other with an incorrect medication altogether (Ohashi et al., 2013). 
Based on these findings, the likelihood of error preventability with smart pump 
technologies was assessed. Since the first two cases involving the clamped medication 
bags were intercepted and communicated to the nurses prior to the medication reaching 
the patient, and since smart pumps at the time of this study couldn’t detect secondary IV 
bag flows, it’s impossible to theoretically predict whether an error would have occurred 
(Ohashi et al., 2013). In error cases 3 and 4, both were human programming errors in 
which the nurse chose an incorrect IV fluid, in this instance normal saline instead of ½ 
normal saline and programmed an incorrect infusion rate. Fortunately, the mistakes were 
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non-critical, causing no harm to the patients, but what’s concerning is the smart pumps’ 
lack of alerts to the nurse that there may be a problem. Moreover, to achieve maximum 
patient protection, the article discusses the need for smart pumps to seamlessly integrate 
or connect with order entry systems and/or the patient’s eMAR; the study further 
comments that only when all medication data including dose, concentration, and rate can 
be retrieved from physician orders on electronic records in real-time can typing and 
selecting errors be eliminated (Ohashi et al., 2013). Based on these findings, the four 
errors were rated unlikely to be prevented by in-use smart pump technology. Table 3 
below illustrates these errors and their likelihood to cause harm.  
 
Error 
case 
# 
NCC 
MER
P 
Type of 
error 
Medication and 
dose infusing via 
IV pump 
Medical record 
order 
Likelihood of 
preventabilit
y with smart 
pump 
technology 
1 C Clamp 
closed 
Cefepime 
2g/50mL, 
16.7m/hr 
(observed at 
9:49am) 
Cefepime 
2g/50mL, 
16.7m/hr 
administered at 
9:02am 
No 
2 C Clamp 
closed 
Phytonadione(vit 
K) 10mg/100mL, 
Phytonadione(vi
t K) 
10mg/100mL, 
No 
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Error 
case 
# 
NCC 
MER
P 
Type of 
error 
Medication and 
dose infusing via 
IV pump 
Medical record 
order 
Likelihood of 
preventabilit
y with smart 
pump 
technology 
50mL/hr(observe
d at 9:49am 
50mL/hr 
administered at 
9:02am 
3 C Right meds 
programmed 
in correct 
channel 
/pump 
1/2Normal Saline 
125mL/h, pump 
programmed as 
Normal Saline 
1/2Normal 
Saline 125mL/h 
Yes(with 
closed loop 
smart pump) 
4 C Rate 
deviation 
Normal Saline 
5mL/h 
Normal Saline 
3mL/h 
Yes(with 
closed loop 
smart pump) 
5 C Incorrect 
info on label 
Heparin 25,000 
unit / 250 mL, 
1250units/hr 
12.5mL/hr, drug 
name on a 
hospital label 
prepared by 
nurses was 
Heparin 25,000 
unit / 250 mL, 
1250units/hr 
12.5mL/hr 
No 
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Error 
case 
# 
NCC 
MER
P 
Type of 
error 
Medication and 
dose infusing via 
IV pump 
Medical record 
order 
Likelihood of 
preventabilit
y with smart 
pump 
technology 
wrong(pharmacy 
label was correct) 
6 C Unauthorize
d medication 
Normal Saline 
5mL/h 
No order No 
Table 3. Examples of errors with potential harms. Copied from “Evaluation of 
Intravenous Medication Errors with Smart Infusion Pumps in an Academic Medical 
Center,” by Ohashi et al., 2013, AMIA Annual Symposium Proceedings, 2013, 1089–
1098. Copyright 2013 by AMIA. Copied with permission. 
 
According to the second study conducted by Nuckols et al. (2008), of the 100 
preventable IV-ADEs that were identified, only 4 cases involved errors matching smart-
pump features, with two of the cases occurring prior to smart pump implementation and 
the remaining two cases occurring after smart pump implementation. The majority of 
preventable IV-ADEs were attributed to other causes. Overall, 29% of preventable IV-
ADEs involved overdoses, 37% involved failure to monitor for potential problems, and 
the remaining 45% occurred due to the caregiver’s failure to intervene when problems 
appeared (Nuckols et al., 2008). Thus, this study also concluded that smart pumps were 
relatively unlikely to prevent medication errors since they were responsible for only 4% 
of the total number of recorded adverse events.  
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The hospital in the third study conducted by Guérin et al. (2015) implemented a 
total of 1,045 smart pumps. The reported number of adverse IV drug events was 
collected before and after the implementation of smart IV pumps. According to 
Guérin et al. (2015), a total of 2,911 events were self-reported by clinical staff in the 
pre-phase (Y0), 3,523 in the initial post-phase (Y1), and 2,788 in the secondary post-
phase (Y2). Since the fluctuations essentially negated one another, this study also 
concluded that there were no risk reductions associated with the implementation of 
smart pumps in the 500-bed mother/child hospital.    
Limitations.  
 All three studies included in this literature review contained limitations. The 
first study was limited in that it was a point prevalence study, versus a long-term 
observational study. Ohashi et al. (2013) asserts that collected data on a single day is 
not always reflective of practices on other days. The sample size was also fairly small 
at N=55. Regarding limitations with the second study, the authors conclude that they 
may have underestimated events matching smart pump functions due to an inability to 
evaluate smart pump logs or observe its users (Nuckols et al., 2008). This study was 
also limited in that it didn’t include a non-ICU patient population. Lastly, the third study 
was limited due to its potential for inaccuracies from a lack of reporting all incidents. 
This is especially true since the events were self-reported and the participants may have 
feared repercussions for their mistakes. Additionally, this study was limited due to its 
focus on a specific patient population.  
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Conclusion. 
This literature review concludes that smart pumps, despite some positive 
societal hype, have the potential to still cause infusion-related errors. When a barcode 
medication administration system, CPOE, and the eMAR are all integrated with a smart 
IV pump, however, this likelihood seems to lessen. Some smart infusion pump vendors, 
such as Hospira, have accomplished this with the innovation of the Plum 360™ Infusion 
System. Using Hospira’s IV Clinical Integration solution, this pump has the remarkable 
capability of integrating with the electronic medical record (EMR). By doing so, 
programming takes place automatically, populating the Plum 360™ Infusion System with 
medication orders sent directly from the pharmacy or the CPOE system (Hospira, 2017). 
Patient safety remains at the forefront of this newly designed smart IV pump due to its 
wireless integration. With the use of Hospira’s Plum 360™ Infusion System, the chances 
of not only programming a pump incorrectly are nearly eliminated, but the chances of 
administering the wrong medication to the right patient are decreased. This, of course, 
only holds true if the provider prescribes the correct medication, the pharmacist validates 
the medication as appropriate for the patient, and the nurse also uses critical thinking and 
sound judgment to confirm clinical appropriateness.  
As previously mentioned, the supplementary processes of prescribing, dispensing, 
and monitoring all play a pivotal role in ensuring that patients receive proper treatments. 
Ultimately, this literature review revealed that smart infusion pumps might not 
significantly reduce adverse drug events after all. It is believed, however, that with the 
expansion of smart pumps’ capabilities and functionalities to integrate with the eMAR, a 
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means of creating a closed loop clinical system, clinical facilities might experience the 
full benefits of IV smart pumps.  
Chapter 3: Methodology 
Research Design.   
This study will be conducted using a descriptive, cross-sectional research design 
method in which data will be collected and analyzed at a specific point in time.  
Population and Sample Design.  
 Research will be conducted on the entire obstetrical registered nursing staff at the 
following five Covenant Health-owned facilities in East Tennessee: Methodist Medical 
Center in Oak Ridge, TN; Parkwest Medical Center in Knoxville, TN; Fort Sanders 
Regional Medical Center in Knoxville, TN; LeConte Medical Center in Sevierville, TN; 
and Morristown-Hamblen Healthcare System in Morristown, TN.  
Data Collection Procedure/Instrument.  
 Data will be collected via survey research. Informed consent of the nursing staff 
will be obtained followed by a brief, standardized questionnaire with seven closed-ended 
questions. The survey, which will be disseminated via the organizations’ email system, 
will be constructed and completed using the free online survey tool, SurveyMonkey®. 
Recipients will be allotted a week’s time to complete the survey. A reminder email will 
be sent out nearing the week end of the survey deadline.  
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Response Rate.  
 To increase the response rate, and as previously mentioned above, a follow-up 
with the respondents in the form of a reminder email will be distributed. A response rate 
of greater than 50 percent is desired.  
Profile of Sample.  
 Only registered nurses who are practicing one-on-one patient care at the bedside 
in an inpatient hospital setting will be included in this study. Licensed practical nurses 
(LPNs) will be excluded. Nurses in administrative and/or non-clinical positions will also 
be excluded from this study.  
Research Questions.  
 The collected data from the surveys will be analyzed using descriptive statistics. 
Specifically, the mean, a measure of central tendency, will be used to provide an 
arithmetic average of all responses. Most of the obtained data will be compared and 
displayed on a bar graph. Data results from the second statement which addresses the 
participants’ primary shift, however, will be analyzed and visually displayed using a pie 
chart.   
Chapter 4: Results 
Response Rate of Sample.  
 As originally intended, the survey was distributed to a total of 187 registered 
nurses across the five previously mentioned Covenant Health-owned facilities in East 
Tennessee. The breakdown for this, according to facility, is as follows: 33 registered 
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nurses from Methodist Medical Center in Oak Ridge, TN; 45 registered nurses from 
Parkwest Medical Center in Knoxville, TN; 12 registered nurses from LeConte Medical 
Center in Sevierville, TN; 72 registered nurses from Fort Sanders Regional Medical 
Center in Knoxville, TN; and 25 registered nurses from Morristown-Hamblen Healthcare 
System in Morristown, TN. Of the 187 total nurses who received the survey, 72 nurses 
completed the survey in its entirety, resulting in a 38.5% response rate.  
Profile of Sample.  
 Nurses who had practiced bedside nursing for 4-10 years had the highest survey 
response rate at 31.94%. Conversely, only 2.78% of registered nurses having practiced 
bedside nursing for less than one year completed the survey. Respondents who had 
practiced bedside nursing for 11-20 years had the same response rate of 22.22% as 
respondents with >20 years of nursing experience. Over half of the survey’s respondents 
work dayshift hours. Nightshift nurses, however, weren’t far behind with a response rate 
of 40.28%. Nurses working PRN or varied shifts had the lowest response rate at 2.78% 
and 1.39%, respectively. Nearly 35% of the survey responses were from nurses 22-30 
years of age. Nurses >60 years of age had the lowest response rate at 6.94%.   
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Research Questions. 
Q1 
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Q2 
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Q3 
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Q4 
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Q5 
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Q6 
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Q7 
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Q8 
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Chapter 5: Summary, Conclusions, and Recommendations 
Summary of Findings.  
 This research study found that nearly all registered nurses agreed that smart IV 
pumps improve patient safety by reducing harm associated with medication errors. Half 
of the respondents simply agreed, while 48.61% strongly agreed. Only one respondent 
determined indifference/uncertainty. Of the 72 registered nurses who were surveyed, 0% 
disagreed or strongly disagreed with smart IV pumps’ abilities to improve patient safety.  
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 According to the survey, respondents reported multiple instances in which smart 
IV pumps had prevented errors in their nursing careers. Of these errors, 56.94% of 
respondents stated that smart IV pumps prevented medication errors, 26.39% of 
respondents reported prevention of IV fluid errors, 20.83% of respondents reported 
prevention of blood/blood product(s)-related errors, 19.44% were unsure if smart IV 
pumps had prevented any errors, and the remaining 13.89% reported that smart IV pumps 
had not prevented any errors.  
 A large majority of respondents, 93.0% to be exact, alleged to some degree that 
smart IV pumps are easy to operate and user-friendly. Only 5.56% were indifferent or 
unsure, while only a single respondent disagreed with this statement. When respondents 
were asked if smart pumps’ eventual integration with the eMAR, CPOE, and barcode 
scanning systems would further improve patient safety, 50.0% strongly agreed, 40.28% 
agreed, 8.33% were indifferent or unsure, a single respondent disagreed, and no 
respondents strongly disagreed with this statement.  
 The last survey question, a free-text comment box, was provided to elicit 
supplementary information/opinions. Two commenters supported the use of IV smart 
pump technology stating, “I would love if we could just scan to program the pump” and 
the other respondent remarked that “the use of smart technology can improve clinical 
safety for patients. Alerts, medications, and rate limits can be customized on a unit level 
and this level of customization provides a safety net for clinical float staff.” Another 
commenter took a different stance as he/she “wants to set my own pump according to 
directions and my need.” And lastly, further input was provided from a respondent who 
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believes that “better tutorials [are] needed for new hires, as brands and functionality 
differ between organizations.”   
Conclusions and Recommendations. 
 This unique study which sought to evaluate the efficacy of smart IV pumps from a 
nursing perspective produced survey results that were largely in favor of smart IV pump 
technology. This study’s results are extremely useful in that no research, to date, has 
assessed the effectiveness/success of smart IV pump technology from the actual user’s 
perspective. Demographically speaking, the results diversely represent registered nurses 
of different age groups with various experience levels. Having a near equal percentage of 
dayshift versus nightshift respondents contributes to the reliability and reality of today’s 
nursing workforce. A plethora of nurses reported multiple instances in which smart IV 
pumps prevented them from making potentially life-threatening errors. In knowing that 
IV medications, when compared with medications delivered via other routes, can produce 
more rapid, potentially irreversible side effects, the fact that 56.94% of respondents were 
able to prevent said errors with the use of IV smart pumps is substantial.  
 It is important to note that the nursing staff that completed this survey currently 
use smart IV pump technology, but not to its full functionality. Smart IV pumps at the 
five facilities have yet to be integrated with the eMAR, CPOE, and barcode scanning 
systems. Because of this, a future study might entail distributing the same survey 
questions after this integration has occurred for result comparison. Additionally, proper 
attention should be called to the fact that >90% of nurses envision this integration as 
helpful in improving patient safety. Moreover, based on the number of responses 
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indicating that a medical error was prevented with the use of smart IV pumps, whether it 
be related to blood/blood products, medications, and/or IV fluids, and in addition to the 
nursing staff’s positivity regarding ease of use and technological advancements, this 
study concludes that the use of smart IV pump technology is recommended in today’s 
healthcare facilities.  
The implementation of smart pump technology by health systems and hospitals 
generally requires considerable planning, including identification of stakeholders, 
evaluation of software capabilities, evaluation of hospital-specific practices, decisions 
regarding standard operating systems and procedures, building of comprehensive drug 
libraries, and education of staff before the pumps can be deployed (Reston, 2013). In 
addition, successful implementation cannot occur without motivated multidisciplinary 
teams that include not only physicians, pharmacists, and nurses, but also members of the 
information technology and informatics teams. With patient safety as the driving force, 
smart infusion pumps, when used appropriately, are becoming an essential technology in 
healthcare all around the globe. 
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